FDA approves Alzheimer’s drug Aduhelm

FDA approves new drug for Alzheimer's disease

The FDA has approved pharmaceutical company Biogen’s Alzheimer’s drug aducanumab, which will be sold under the name Aduhelm. This is the first FDA approved drug for the treatment of Alzheimer’s in almost two decades. The drug is slated as being the first to show significant progress against the sticky brain plaques that are the feature … Read more